U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea · Delayed Price · Currency is KRW 20,750
-1,850 (-8.19%)
At close: Mar 19, 2026
U2Bio Revenue
In the year 2025, U2Bio had annual revenue of 25.59B KRW with 2.21% growth. U2Bio had revenue of 6.27B in the quarter ending December 31, 2025, with 0.11% growth.
Revenue
25.59B
Revenue Growth
+2.21%
P/S Ratio
11.83
Revenue / Employee
n/a
Employees
n/a
Market Cap
302.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 25.59B | 552.73M | 2.21% |
| Dec 31, 2024 | 25.04B | -5.75B | -18.68% |
| Dec 31, 2023 | 30.79B | -38.22B | -55.38% |
| Dec 31, 2022 | 69.01B | 58.01B | 527.29% |
| Dec 31, 2014 | 11.00B | 1.59B | 16.90% |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Com2uS | 704.37B |
| Ace Bed Company | 317.27B |
| InBody Co.,Ltd | 226.62B |
| Webzen | 174.44B |
| Smec Co.,Ltd | 161.95B |
| Jaeyoung Solutec | 142.23B |
| Daemyoung Energy Co.,Ltd | 98.77B |
| Mecaro | 91.22B |